Dental Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2017

  • ID: 4196185
  • Report
  • 82 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • 3-D Matrix Ltd
  • botiss dental GmbH
  • curasan AG
  • Maxigen Biotech Inc
  • Medtronic plc
  • NovaBone Products LLC
  • MORE
Dental Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2017

Summary

The author's Medical Devices sector report, “Dental Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2017" provides an overview of Dental Bone Graft Substitutes currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and the number of trials for the key Dental Bone Graft Substitutes pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by an expert team of industry experts.

- Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Dental Bone Graft Substitutes under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Dental Bone Graft Substitutes and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry

Reasons to buy

The report enables you to:

- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Dental Bone Graft Substitutes under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3-D Matrix Ltd
  • botiss dental GmbH
  • curasan AG
  • Maxigen Biotech Inc
  • Medtronic plc
  • NovaBone Products LLC
  • MORE
1 Table of Contents
2 Introduction
2.1 Dental Bone Graft Substitutes Overview
3 Products under Development
3.1 Dental Bone Graft Substitutes - Pipeline Products by Stage of Development
3.2 Dental Bone Graft Substitutes - Pipeline Products by Territory
3.3 Dental Bone Graft Substitutes - Pipeline Products by Regulatory Path
3.4 Dental Bone Graft Substitutes - Pipeline Products by Estimated Approval Date
3.5 Dental Bone Graft Substitutes - Ongoing Clinical Trials
4 Dental Bone Graft Substitutes - Pipeline Products under Development by Companies
4.1 Dental Bone Graft Substitutes Companies - Pipeline Products by Stage of Development
4.2 Dental Bone Graft Substitutes - Pipeline Products by Stage of Development
5 Dental Bone Graft Substitutes Companies and Product Overview
5.1 3-D Matrix Ltd Company Overview
5.1.1 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.2 botiss dental GmbH Company Overview
5.2.1 botiss dental GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.3 curasan AG Company Overview
5.3.1 curasan AG Pipeline Products & Ongoing Clinical Trials Overview
5.4 Maxigen Biotech Inc Company Overview
5.4.1 Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Medtronic plc Company Overview
5.5.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.6 NovaBone Products LLC Company Overview
5.6.1 NovaBone Products LLC Pipeline Products & Ongoing Clinical Trials Overview
5.7 PolyPid Ltd Company Overview
5.7.1 PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.8 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.8.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
5.9 University of Maryland Company Overview
5.9.1 University of Maryland Pipeline Products & Ongoing Clinical Trials Overview
6 Dental Bone Graft Substitutes- Recent Developments
6.1 Mar 22, 2017: Straumann Group presents numerous innovations at the 37th International Dental Show in Cologne
6.2 Mar 21, 2017: Medtronic Prices Public Offering of 1.7% Notes Due 2019 for USD1 Billion
6.3 Mar 21, 2017: Medtronic Prices Public Offering of 3.35% Notes Due 2027 for USD850 Million
6.4 Mar 21, 2017: Medtronic Prices Public Offering of 4.625% Notes Due 2045 for USD150 Million
6.5 Mar 20, 2017: Straumann Group strengthens executive team to sustain dynamic growth in APAC and to lead Global People Management & Development
6.6 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
6.7 Feb 21, 2017: Exactech 2016 Revenue Up 7% to $257.6 Million, Q4’16 Revenue Increased 6% to $66.2 Million
6.8 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
6.9 Jan 31, 2017: Antibe Therapeutics Announces the Launch of PentOS OI Max, its Newest Bone Graft Substitute for Oral and Maxillofacial Surgery
6.10 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook
6.11 Jan 10, 2017: Stryker provides 2016 preliminary net sales results
6.12 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
6.13 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
6.14 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction
6.15 Nov 10, 2016: Curasan Continues Dynamic Growth in the Third Quarter
6.16 Oct 31, 2016: Exactech Q3 Revenue Up 7% to $59.9 Million. Net Income up 10% to $3.2 Million. Diluted EPS $0.22 vs. $0.20.
6.17 Oct 27, 2016: Stryker reports third quarter 2016 results
6.18 Oct 27, 2016: Another Strong Quarter (+13% Organic) Keeps Straumann On Track To Achieve Full-Year Targets
6.19 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
6.20 Aug 25, 2016: Medtronic Reports First Quarter Financial Results
6.21 Aug 23, 2016: Strong Performance Continues As Organic Growth Of 14% Lifts First-Half Revenue To Record Level
6.22 Aug 23, 2016: Straumann reports strong performance continues as organic growth of 14% lifts first-half revenue to record level
6.23 Aug 18, 2016: curasan accelerates sales growth in the first six months due to rising foreign demand
6.24 Aug 16, 2016: NovaBone Products Receives GMP Medical Device Certificate
6.25 Aug 01, 2016: Exactech Q2 Revenue Up 8% to $66.1 Million; Net Income up 20% to $4.4 Million; Diluted EPS $0.31 vs. $0.26
6.26 Jul 21, 2016: Stryker reports second quarter 2016 results
6.27 Jul 18, 2016: Straumann takes over distribution of botiss products in Germany
6.28 Jul 14, 2016: Straumann to Acquire Controlling Stake in MegaGen
6.29 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic
6.30 Jun 27, 2016: Dentsply Sirona to Acquire MIS Implants Technologies for USD375 Million
6.31 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day
6.32 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results
6.33 May 23, 2016: Straumann Announces Change In Board Of Directors And Compensation Committee
6.34 May 11, 2016: curasan posts sales growth in the first quarter
6.35 May 03, 2016: Straumann reports strong start to the year with organic revenue growth of 12% in Q1
6.36 Apr 28, 2016: Curasan: Annual results influenced by positive trends in growth regions
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Dental Bone Graft Substitutes - Pipeline Products by Stage of Development
Table 2: Dental Bone Graft Substitutes - Pipeline Products by Territory
Table 3: Dental Bone Graft Substitutes - Pipeline Products by Regulatory Path
Table 4: Dental Bone Graft Substitutes - Pipeline Products by Estimated Approval Date
Table 5: Dental Bone Graft Substitutes - Ongoing Clinical Trials
Table 6: Dental Bone Graft Substitutes Companies - Pipeline Products by Stage of Development
Table 7: Dental Bone Graft Substitutes - Pipeline Products by Stage of Development
Table 8: 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 9: TDM-711 - Product Status
Table 10: TDM-711 - Product Description
Table 11: botiss dental GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 12: maxresorb - Product Status
Table 13: maxresorb - Product Description
Table 14: maxresorb Inject - Product Status
Table 15: maxresorb Inject - Product Description
Table 16: perossal - Product Status
Table 17: perossal - Product Description
Table 18: curasan AG Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Cerasorb Foam Dental - Product Status
Table 20: Cerasorb Foam Dental - Product Description
Table 21: Cerasorb Paste Dental - Product Status
Table 22: Cerasorb Paste Dental - Product Description
Table 23: Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: MaxiBone - Product Status
Table 25: MaxiBone - Product Description
Table 26: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: MD05-P Bone Graft Substitute Material - Product Status
Table 28: MD05-P Bone Graft Substitute Material - Product Description
Table 29: NovaBone Products LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Bioengineered Resorbable Bone Graft - Dental - Product Status
Table 31: Bioengineered Resorbable Bone Graft - Dental - Product Description
Table 32: PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 33: BonyPid-500 - Product Status
Table 34: BonyPid-500 - Product Description
Table 35: PolyPid Ltd - Ongoing Clinical Trials Overview
Table 36: BonyPid-500 - PolyPid, Ltd. Pilot Study of the BonyPid-500 Bone Graft Substitute
Table 37: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 38: BioCaS - Product Status
Table 39: BioCaS - Product Description
Table 40: University of Maryland Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Injectable Scaffold - Product Status
Table 42: Injectable Scaffold - Product Description
Table 43: Glossary

List of Figures
Figure 1: Dental Bone Graft Substitutes - Pipeline Products by Stage of Development
Figure 2: Dental Bone Graft Substitutes - Pipeline Products by Territory
Figure 3: Dental Bone Graft Substitutes - Pipeline Products by Regulatory Path
Figure 4: Dental Bone Graft Substitutes - Pipeline Products by Estimated Approval Date
Figure 5: Dental Bone Graft Substitutes - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3-D Matrix Ltd
  • botiss dental GmbH
  • curasan AG
  • Maxigen Biotech Inc
  • Medtronic plc
  • NovaBone Products LLC
  • PolyPid Ltd
  • Sree Chitra Tirunal Institute for Medical Sciences & Technolog
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll